These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4021183)

  • 1. [Determination of polyamines in plasma and erythrocytes of patients with chronic renal failure].
    Saito A; Takagi T; Chung TG
    Nihon Jinzo Gakkai Shi; 1985 Feb; 27(2):183-8. PubMed ID: 4021183
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of amino acids and polyamines in human erythrocytes. Part 2. Clinical application.
    Tokunaga A
    Hiroshima J Med Sci; 1983 Mar; 32(1):127-43. PubMed ID: 6345477
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thiamine penetration into erythrocytes of patients with chronic renal failure treated with repeated dialyses].
    Kopczyński Z; Chmiel J; Baczyk K; Czarnecki R
    Pol Tyg Lek; 1982 Mar; 37(1):13-5. PubMed ID: 7111064
    [No Abstract]   [Full Text] [Related]  

  • 4. Zinc in plasma and red blood cells of children with chronic renal failure.
    López-Uriarte A; Ramos-Contreras P; Díaz-Bensussen S; López-Montaño E; Vargas-Rosendo R
    Arch Invest Med (Mex); 1984; 15(1):45-54. PubMed ID: 6477025
    [No Abstract]   [Full Text] [Related]  

  • 5. Zinc and copper concentration in plasma and erythrocytes of patients with chronic renal failure.
    Paniagua-Sierra JR; Pérez-López A; Diaz-Bensussen S; Solís-Alpuche L; Saavedra-Guatemala H; Exaire-Murad JE
    Arch Invest Med (Mex); 1981; 12(1):69-82. PubMed ID: 7247613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sodium and potassium content of erythrocytes at the terminal stage of chronic renal insufficiency and during treatment by chronic hemodialysis].
    Terekhov NT; Goligorskiĭ MS; Kremen' MG; Vasilenko VK
    Urol Nefrol (Mosk); 1974; (6):10-4. PubMed ID: 4141153
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of polyamines in hydrolysates of uremic plasma by high-performance cation-exchange column chromatography.
    Takagi T; Chung TG; Saito A
    J Chromatogr; 1983 Feb; 272(2):279-85. PubMed ID: 6833425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyamines as an inhibitor on erythropoiesis of hemodialysis patients by in vitro bioassay using the fetal mouse liver assay.
    Yoshida K; Yoneda T; Kimura S; Fujimoto K; Okajima E; Hirao Y
    Ther Apher Dial; 2006 Jun; 10(3):267-72. PubMed ID: 16817792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Free erythropoietic protoporphyrins in chronic renal insufficiency].
    Tabernero Romo JM; Rodríguez Commes JL; Macias Núñez JF; Bondia Roman A; Corbacho Becerra L; Juanes González A; de Castro del Pozo S
    Rev Clin Esp; 1978 Jul; 150(1-2):31-4. PubMed ID: 704989
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum levels of polyamines in patients with chronic renal failure.
    Saito A; Takagi T; Chung TG; Ohta K
    Kidney Int Suppl; 1983 Dec; 16():S234-7. PubMed ID: 6588257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glyceraldehydephosphate dehydrogenase activity in the erythrocytes of patients with terminal chronic renal failure treated with repeated dialysis].
    Kopczyński Z; Chmiel J; Dryl T; Czarnecki R
    Pol Tyg Lek; 1982 Oct; 37(39):1157-9. PubMed ID: 7163058
    [No Abstract]   [Full Text] [Related]  

  • 12. [Correction of acid-base imbalance in patients with chronic renal failure during hemodialysis].
    Khodas MIa; Piatnitskaia GKh; Levitskiĭ ER; Sagalovich GM; Petrosova MA
    Klin Med (Mosk); 1974 Mar; 52(3):47-53. PubMed ID: 4466949
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of dialysis membranes on lipid peroxidation in erythrocytes of patients with terminal renal failure].
    Kubatiev AA; Rud'ko IA; Balashova TS; Ermolenko VM
    Biull Eksp Biol Med; 1994 Nov; 118(11):460-2. PubMed ID: 7888639
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma, red cell and cerebrospinal fluid concentrations of myoinositol in patients with severe chronic renal failure.
    Servo C; Bardy A; Pasternack A; Pitkänen E
    Ann Clin Res; 1976 Dec; 8(6):374-7. PubMed ID: 1008476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of dialysis treatment on the oxygen affinity of hemoglobin in chronic kidney failure].
    Amor H; Humpeler E; Dittrich P
    Schweiz Med Wochenschr; 1974 Mar; 104(13):453-8. PubMed ID: 4824416
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell cholesterol transport to plasma in blood from patients with renal failure or a kidney transplant.
    Sutherland WH; Corboy J; Walker RJ; Robertson MC; Ball MJ
    Nephrol Dial Transplant; 1995; 10(3):358-65. PubMed ID: 7792031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum vitamin E and fatty acid composition of the red cell membrane phospholipids in patients with chronic renal failure treated by hemodialysis.
    Heldenberg D; Blum M; Levtow O; Maisner I
    Clin Nephrol; 1982 Nov; 18(5):272. PubMed ID: 7151344
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical significance of the folic acid content in plasma and erythrocytes].
    Heilmann E; Bönninghoff E
    Acta Biol Med Ger; 1977; 36(5-6):805-8. PubMed ID: 602586
    [No Abstract]   [Full Text] [Related]  

  • 19. The relationship between the magnesium concentration in the dialysis fluid used and in the plasma and erythrocytes of patients with chronic renal failure being treated by regular haemodialysis.
    Heierli C; Hill AV
    Clin Sci; 1972 Dec; 43(6):779-87. PubMed ID: 4646274
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sodium and potassium concentrations in the erythrocytes of patients undergoing chronic hemodialysis. (I)--Effects of hemodialysis on the erythrocyte sodium and potassium concentrations (author's transl)].
    Imada A; Horiuchi A; Kawauchi Y; Kogi Y
    Rinsho Byori; 1982 Jan; 30(1):82-6. PubMed ID: 7087235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.